Predict your next investment

RoosterBio company logo
HEALTHCARE | Biotechnology
roosterbio.com

See what CB Insights has to offer

Executives

3

Board of Directors

4

RoosterBio Board of Directors

4 Board of directors

RoosterBio has 4 board of directors, including Daniella Kranjac.

Name

Firm

Work History

Other Seats

Daniella Kranjac

Daniella Kranjac has been building life sciences businesses, developing and commercializing life sciences products for over 16 years. Having co-founded Wave Biotech LLC from her dormitory room, she and a partner drove the start-up, growth, and commercialization of a highly disruptive technology. As Vice President of the organization, Daniella established a high growth company with significant brand recognition, and led the group to a successful exit and acquisition by GE Healthcare in 2007.

Envisagenics, and FloDesign Sonics

George Bickerstaff

Axovant, CareDx, InCarda Therapeutics, Innoviva, Inovio Pharmaceuticals, and International Vaccine Institute

Robert Carlson

Founder and President Rob Carlson is our chief strategist. He is the author of the book Biology is Technology, published by Harvard Press. In the development of the computer industry, Moore's Law predicted exponential growth - a doubling of computing power per dollar every 18 months. In 2006, The Economist magazine named the biotechnological equivalent of Moore's Law the Carlson Curve after Rob. He co-founded Bioeconomy Management, LLC in order to help scientist founders in synthetic biology and related areas round out the rest of their teams, by providing an experienced executive team on the business side - especially focused on investor communications.

Lumen Bioscience

Timothy Askew

Name

Daniella Kranjac

George Bickerstaff

Robert Carlson

Timothy Askew

Firm

Work History

Daniella Kranjac has been building life sciences businesses, developing and commercializing life sciences products for over 16 years. Having co-founded Wave Biotech LLC from her dormitory room, she and a partner drove the start-up, growth, and commercialization of a highly disruptive technology. As Vice President of the organization, Daniella established a high growth company with significant brand recognition, and led the group to a successful exit and acquisition by GE Healthcare in 2007.

Founder and President Rob Carlson is our chief strategist. He is the author of the book Biology is Technology, published by Harvard Press. In the development of the computer industry, Moore's Law predicted exponential growth - a doubling of computing power per dollar every 18 months. In 2006, The Economist magazine named the biotechnological equivalent of Moore's Law the Carlson Curve after Rob. He co-founded Bioeconomy Management, LLC in order to help scientist founders in synthetic biology and related areas round out the rest of their teams, by providing an experienced executive team on the business side - especially focused on investor communications.

Other Seats

Envisagenics, and FloDesign Sonics

Axovant, CareDx, InCarda Therapeutics, Innoviva, Inovio Pharmaceuticals, and International Vaccine Institute

Lumen Bioscience

RoosterBio Management Team

3 Team Members

RoosterBio has 3 executives. RoosterBio's current Chief Technology Officer is Jon A Rowley.

Name

Work History

Title

Status

Jon A Rowley

Chief Technology Officer

Current

Margot Connor

Chief Executive Officer

Current

Uplaksh S Kumar

Chief Operating Officer

Former

Name

Jon A Rowley

Margot Connor

Uplaksh S Kumar

Work History

Title

Chief Technology Officer

Chief Executive Officer

Chief Operating Officer

Status

Current

Current

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.